A Clinical Study on Effect of Vyoshadi Guggulu on Patients Having Uterine Fibroids
Phase 3
- Conditions
- Health Condition 1: N719- Inflammatory disease of uterus, unspecifiedHealth Condition 2: N858- Other specified noninflammatory disorders of uterus
- Registration Number
- CTRI/2024/01/061394
- Lead Sponsor
- Dr Iram Sayed
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1.Pt having single or multiple Uterine Fibroids of less than 5cms
Exclusion Criteria
1.Patient having fibroid of size more than 5 cm as per USG report.
2.Ovarian tumour, tubo-ovarian mass and malignant tumours along with fibroid.
3.Prediagnosed Cases of Cancer.
4.Patient below the age of 20 years and above the age of 50years.
5.Women with Hb < 7 gm%.
6.Pregnant women with fibroid.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Vyoshadi guggulu is Effective in management of Uterine Fibroids given orally everyday for 3 consecutive mnths assessed every month symptomatically n final outcome after 3 monthsTimepoint: Monthly
- Secondary Outcome Measures
Name Time Method Vyoshadi Guggulu Does not have any role in management of Uterine FibroidsTimepoint: Monthly